HK Stock MarketDetailed Quotes

09618 JD-SW

Watchlist

144.200
-0.200-0.14%

Trading Dec 16 11:57 CST

418.04BMarket Cap10.80P/E (TTM)

JD-SW Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Turnover

4.27%811.83B

3.87%551.45B

7.04%260.05B

3.67%1.08T

3.70%778.59B

4.66%530.89B

1.38%242.96B

9.95%1.05T

11.12%750.79B

11.00%507.26B

Operating income

4.27%811.83B

3.87%551.45B

7.04%260.05B

3.67%1.08T

3.70%778.59B

4.66%530.89B

1.38%242.96B

9.95%1.05T

11.12%750.79B

11.00%507.26B

Cost of sales

-2.82%-681.08B

-2.71%-465.74B

-6.45%-220.28B

-2.87%-924.96B

-2.65%-662.38B

-3.54%-453.44B

-0.35%-206.94B

-9.32%-899.16B

-10.54%-645.25B

-10.55%-437.92B

Operating expenses

-2.82%-681.08B

-2.71%-465.74B

-6.45%-220.28B

-2.87%-924.96B

-2.65%-662.38B

-3.54%-453.44B

-0.35%-206.94B

-9.32%-899.16B

-10.54%-645.25B

-10.55%-437.92B

Gross profit

12.52%130.75B

10.66%85.71B

10.42%39.77B

8.59%159.7B

10.11%116.2B

11.70%77.45B

7.69%36.02B

13.95%147.07B

14.78%105.54B

13.95%69.34B

Selling expenses

-15.16%-31.12B

-10.77%-21.12B

-15.60%-9.25B

-6.25%-40.13B

-4.79%-27.02B

-4.87%-19.07B

8.04%-8.01B

2.51%-37.77B

-1.60%-25.79B

-3.24%-18.18B

Administrative expenses

12.27%-6.43B

15.46%-4.11B

20.99%-1.98B

12.15%-9.71B

1.01%-7.33B

-1.48%-4.86B

-1.58%-2.5B

4.40%-11.05B

5.32%-7.41B

-0.29%-4.79B

Research and development expenses

-4.94%-12.65B

0.08%-8.25B

3.63%-4.03B

2.96%-16.39B

3.79%-12.05B

1.82%-8.26B

4.52%-4.19B

-3.43%-16.89B

-2.45%-12.53B

-2.29%-8.41B

Profit from asset sales

----

65.55%2.28B

20.50%1.48B

--1.48B

--472M

79.79%1.38B

64.13%1.23B

----

Impairment and provision

----

---5.17B

----

-Goodwill impairment

----

---3.14B

----

-Other impairment is provision

----

---2.03B

----

Special items of operating profit

-6.41%-50.31B

-6.17%-34.03B

-9.34%-16.81B

-2.46%-64.56B

-2.44%-47.28B

-0.81%-32.05B

0.74%-15.37B

-6.70%-63.01B

-8.00%-46.15B

-11.74%-31.79B

Operating profit

26.02%30.25B

23.84%18.2B

19.81%7.7B

31.95%26.03B

61.13%24B

138.36%14.7B

166.79%6.43B

376.29%19.72B

228.59%14.9B

214.43%6.17B

Financing cost

-0.82%-1.97B

-3.62%-1.29B

-1.86%-601M

-36.80%-2.88B

-38.78%-1.95B

-50.24%-1.24B

-71.01%-590M

-73.62%-2.11B

-83.74%-1.41B

-68.64%-828M

Special items of earning before tax

84.96%11.65B

90.00%7.77B

-0.25%1.97B

326.83%8.51B

283.29%6.3B

236.44%4.09B

139.59%1.97B

31.92%-3.75B

-183.05%-3.44B

-181.02%-3B

Earning before tax

40.86%39.92B

40.70%24.68B

16.10%9.07B

128.24%31.65B

182.00%28.34B

649.34%17.54B

367.86%7.81B

637.48%13.87B

293.73%10.05B

-54.71%2.34B

Tax

12.44%-6.13B

15.79%-3.72B

-5.66%-1.7B

-100.98%-8.39B

-95.45%-7B

-141.40%-4.42B

-166.83%-1.61B

-121.30%-4.18B

-110.48%-3.58B

-74.55%-1.83B

After-tax profit from continuing operations

58.33%33.8B

59.72%20.96B

18.81%7.37B

139.99%23.26B

229.91%21.35B

2,472.94%13.12B

276.21%6.2B

316.95%9.69B

659.89%6.47B

-87.62%510M

Earning after tax

58.33%33.8B

59.72%20.96B

18.81%7.37B

139.99%23.26B

229.91%21.35B

2,472.94%13.12B

276.21%6.2B

316.95%9.69B

659.89%6.47B

-87.62%510M

Minority profit

304.06%2.29B

323.21%1.19B

479.03%235M

-32.08%-910M

164.58%567M

132.00%280M

88.24%-62M

24.04%-689M

-16.51%-878M

-199.66%-875M

Profit attributable to shareholders

51.63%31.51B

53.98%19.77B

13.88%7.13B

132.82%24.17B

182.77%20.78B

827.22%12.84B

309.33%6.26B

391.57%10.38B

357.82%7.35B

-68.61%1.39B

Basic earnings per share

57.94%10.44

57.46%6.44

14.57%2.28

131.63%7.69

181.28%6.61

808.89%4.09

307.29%1.99

388.70%3.32

351.92%2.35

-68.31%0.45

Diluted earnings per share

55.81%10.19

56.93%6.34

15.82%2.27

137.07%7.61

194.59%6.54

839.53%4.04

304.17%1.96

379.13%3.21

344.00%2.22

-68.84%0.43

Currency Unit

CNY

Accounting Standards

UAS

Audit Opinions

Unqualified Opinion

Auditor

Deloitte Guan Huang Chen Fang, PricewaterhouseCoopers

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Turnover	4.27%811.83B	3.87%551.45B	7.04%260.05B	3.67%1.08T	3.70%778.59B	4.66%530.89B	1.38%242.96B	9.95%1.05T	11.12%750.79B	11.00%507.26B
Operating income	4.27%811.83B	3.87%551.45B	7.04%260.05B	3.67%1.08T	3.70%778.59B	4.66%530.89B	1.38%242.96B	9.95%1.05T	11.12%750.79B	11.00%507.26B
Cost of sales	-2.82%-681.08B	-2.71%-465.74B	-6.45%-220.28B	-2.87%-924.96B	-2.65%-662.38B	-3.54%-453.44B	-0.35%-206.94B	-9.32%-899.16B	-10.54%-645.25B	-10.55%-437.92B
Operating expenses	-2.82%-681.08B	-2.71%-465.74B	-6.45%-220.28B	-2.87%-924.96B	-2.65%-662.38B	-3.54%-453.44B	-0.35%-206.94B	-9.32%-899.16B	-10.54%-645.25B	-10.55%-437.92B
Gross profit	12.52%130.75B	10.66%85.71B	10.42%39.77B	8.59%159.7B	10.11%116.2B	11.70%77.45B	7.69%36.02B	13.95%147.07B	14.78%105.54B	13.95%69.34B
Selling expenses	-15.16%-31.12B	-10.77%-21.12B	-15.60%-9.25B	-6.25%-40.13B	-4.79%-27.02B	-4.87%-19.07B	8.04%-8.01B	2.51%-37.77B	-1.60%-25.79B	-3.24%-18.18B
Administrative expenses	12.27%-6.43B	15.46%-4.11B	20.99%-1.98B	12.15%-9.71B	1.01%-7.33B	-1.48%-4.86B	-1.58%-2.5B	4.40%-11.05B	5.32%-7.41B	-0.29%-4.79B
Research and development expenses	-4.94%-12.65B	0.08%-8.25B	3.63%-4.03B	2.96%-16.39B	3.79%-12.05B	1.82%-8.26B	4.52%-4.19B	-3.43%-16.89B	-2.45%-12.53B	-2.29%-8.41B
Profit from asset sales	----	----	----	65.55%2.28B	20.50%1.48B	--1.48B	--472M	79.79%1.38B	64.13%1.23B	----
Impairment and provision	----	----	----	---5.17B	----	----	----	----	----	----
-Goodwill impairment	----	----	----	---3.14B	----	----	----	----	----	----
-Other impairment is provision	----	----	----	---2.03B	----	----	----	----	----	----
Special items of operating profit	-6.41%-50.31B	-6.17%-34.03B	-9.34%-16.81B	-2.46%-64.56B	-2.44%-47.28B	-0.81%-32.05B	0.74%-15.37B	-6.70%-63.01B	-8.00%-46.15B	-11.74%-31.79B
Operating profit	26.02%30.25B	23.84%18.2B	19.81%7.7B	31.95%26.03B	61.13%24B	138.36%14.7B	166.79%6.43B	376.29%19.72B	228.59%14.9B	214.43%6.17B
Financing cost	-0.82%-1.97B	-3.62%-1.29B	-1.86%-601M	-36.80%-2.88B	-38.78%-1.95B	-50.24%-1.24B	-71.01%-590M	-73.62%-2.11B	-83.74%-1.41B	-68.64%-828M
Special items of earning before tax	84.96%11.65B	90.00%7.77B	-0.25%1.97B	326.83%8.51B	283.29%6.3B	236.44%4.09B	139.59%1.97B	31.92%-3.75B	-183.05%-3.44B	-181.02%-3B
Earning before tax	40.86%39.92B	40.70%24.68B	16.10%9.07B	128.24%31.65B	182.00%28.34B	649.34%17.54B	367.86%7.81B	637.48%13.87B	293.73%10.05B	-54.71%2.34B
Tax	12.44%-6.13B	15.79%-3.72B	-5.66%-1.7B	-100.98%-8.39B	-95.45%-7B	-141.40%-4.42B	-166.83%-1.61B	-121.30%-4.18B	-110.48%-3.58B	-74.55%-1.83B
After-tax profit from continuing operations	58.33%33.8B	59.72%20.96B	18.81%7.37B	139.99%23.26B	229.91%21.35B	2,472.94%13.12B	276.21%6.2B	316.95%9.69B	659.89%6.47B	-87.62%510M
Earning after tax	58.33%33.8B	59.72%20.96B	18.81%7.37B	139.99%23.26B	229.91%21.35B	2,472.94%13.12B	276.21%6.2B	316.95%9.69B	659.89%6.47B	-87.62%510M
Minority profit	304.06%2.29B	323.21%1.19B	479.03%235M	-32.08%-910M	164.58%567M	132.00%280M	88.24%-62M	24.04%-689M	-16.51%-878M	-199.66%-875M
Profit attributable to shareholders	51.63%31.51B	53.98%19.77B	13.88%7.13B	132.82%24.17B	182.77%20.78B	827.22%12.84B	309.33%6.26B	391.57%10.38B	357.82%7.35B	-68.61%1.39B
Basic earnings per share	57.94%10.44	57.46%6.44	14.57%2.28	131.63%7.69	181.28%6.61	808.89%4.09	307.29%1.99	388.70%3.32	351.92%2.35	-68.31%0.45
Diluted earnings per share	55.81%10.19	56.93%6.34	15.82%2.27	137.07%7.61	194.59%6.54	839.53%4.04	304.17%1.96	379.13%3.21	344.00%2.22	-68.84%0.43
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	UAS	UAS	UAS	UAS	UAS	UAS	UAS	UAS	UAS	UAS
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--	--
Auditor	--	--	--	Deloitte Guan Huang Chen Fang, PricewaterhouseCoopers	--	--	--	Deloitte Guan Huang Chen Fang, PricewaterhouseCoopers	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.